IGEA Pharma N.V. Announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was USD 0 compared to USD 46,800.000000 a year ago. Operating loss was USD 356,700.000000 compared to USD 536,000 a year ago. Net loss was USD 289,700.000000 compared to USD 543,400.000000 a year ago. Basic loss per share from continuing operations was USD 0.012 compared to USD 0.022 a year ago. Diluted loss per share from continuing operations was USD 0.011 compared to USD 0.022 a year ago.